SCHEMBL1760849

SCHEMBL1760849

C1COB(N=NB2CCCO2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9452386 0.97
SCHEMBL5576712 0.58
SCHEMBL12927348 0.58
SCHEMBL597103 0.58
SCHEMBL21806726 0.58
SCHEMBL3961837 0.53 TSHR (0.42)
SCHEMBL6240283 0.53 ALDH1A1 (0.36)
SCHEMBL18292088 0.51 ALDH1A1 (0.33)
SCHEMBL14832691 0.51
SCHEMBL752992 0.48

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752496-A1 METHODS AND INTERMEDIATES FOR PREPARING A THERAPEUTIC COMPOUND USEFUL IN THE TREATMENT OF RETROVIRIDAE VIRAL INFECTION GILEAD SCIENCES, INC. (US) 2020-12-23 EP claimed
WO-2019161280-A1 METHODS AND INTERMEDIATES FOR PREPARING A THERAPEUTIC COMPOUND USEFUL IN THE TREATMENT OF RETROVIRIDAE VIRAL INFECTION GILEAD SCIENCES, INC. (US) 2019-08-22 WO claimed
WO-2018138500-A1 PROCESS FOR PREPARING PURINE DERIVATIVES CYCLACEL LIMITED (GB) 2018-08-02 WO claimed
EP-3071563-A1 ANTI-CANCER AGENTS AND PREPARATION THEREOF Purdue Research Foundation (US) 2016-09-28 EP claimed
WO-2015077370-A1 ANTI-CANCER AGENTS AND PREPARATION THEREOF PURDUE RESEARCH FOUNDATION (US) 2015-05-28 WO claimed
EP-0962451-A2 Chiral catalysts for reduction of ketones and process for their preparation MERCK &amp; CO. INC. (US) 1999-12-08 EP claimed
EP-0668266-A1 Chiral catalysts for reduction of ketones and process for their preparation MERCK & CO. INC. (US) 1995-08-23 EP claimed
EP-0453298-A2 Chiral catalysts for reduction of ketones and process for their preparation MERCK & CO. INC. (US) 1991-10-23 EP claimed
JP-6080641-A None JP disclosed
JP-4224556-A None JP disclosed
JP-7109231-A None JP disclosed
EP-3897652-A1 SUBSTITUTED PYRAZOLOPYRIMIDINES AND SUBSTITUTED PURINES AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS KSQ Therapeutics, Inc. (US) 2021-10-27 EP disclosed
EP-3752496-A1 METHODS AND INTERMEDIATES FOR PREPARING A THERAPEUTIC COMPOUND USEFUL IN THE TREATMENT OF RETROVIRIDAE VIRAL INFECTION GILEAD SCIENCES, INC. (US) 2020-12-23 EP disclosed
WO-2020132269-A1 SUBSTITUTED PYRAZOLOPYRIMIDINES AND SUBSTITUTED PURINES AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS KSQ Therapeutics, Inc. (US) 2020-06-25 WO disclosed
JP-H0680641-A PRODUCTION OF OPTICALLY ACTIVE 5-HYDROXYBENZOAZEPINE DERIVATIVE OTSUKA PHARMACEUT CO LTD 1994-03-22 JP disclosed
WO-1993020036-A1 TOTAL SYNTHESIS OF TAXOL SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1993-10-14 WO disclosed
US-5177063-A AVERMECTIN COMPOUNDS WITH A 6,5-SPIROKETAL RING SYSTEM MERCK & CO., INC. (US) 1993-01-05 US disclosed
EP-0503885-A1 Avermectin compounds with a 6,5-spiroketal ring system MERCK & CO. INC. (US) 1992-09-16 EP disclosed
JP-H04224556-A CHIRAL CATALYST FOR REDUCING KETONE, AND PREPARATION THEREOF MERCK & CO INC 1992-08-13 JP disclosed
EP-0305180-A2 Enantioselective reduction of ketones THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1989-03-01 EP disclosed